{"name":"Lotus Pharmaceutical","slug":"lotus-pharmaceutical","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Denosin® and Xyzal®","genericName":"Denosin® and Xyzal®","slug":"denosin-and-xyzal","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Denosin® and Xyzal®","genericName":"Denosin® and Xyzal®","slug":"denosin-and-xyzal","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxOX1VmWEtNd1hobHpFTEh2Tm41RVh5VHEwa29nbllFNXBrU0FQM0ZIX053SlFldktobTJ5elBGMmNadXhYVm8zRm5yTUI3dW9zbjl1cXFkaEtrRXdzRjJmTVNqSU04b3ZZNG1IMWYya2FTUlNZVUNqS3I0ekRRTW9WUmpNNDRRTGpEdzd0SDVEQmpxc1A3bmpLSlIzRVo4QXQwb3ZtaXhn?oc=5","date":"2026-03-20","type":"pipeline","source":"marketscreener.com","summary":"Lotus Pharmaceuticals Navigates a Market in Motion - marketscreener.com","headline":"Lotus Pharmaceuticals Navigates a Market in Motion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxPRG1zOVc1QW40dE96STRFS0VQTlMtUVlSOHlpRWdvVjI1aE5SS09tcGxtZ2M3VFlaRE1RUXFnM0tuR19SM3JLUms0UXhzXzZiR2FqckVLQTVrUlV6TkR5N0tLa0h4b0Y1aUE0VmlocWh5ZFJQam5IbnVRNkRfcUluX1NJU3IyNGs?oc=5","date":"2025-12-08","type":"deal","source":"Bangkok Post","summary":"Innobic buys Alvogen Pharma - Bangkok Post","headline":"Innobic buys Alvogen Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxOa2FTZTk1OC1aZGFMY1JDeWVWOGFMajJhaWxBOVlnNnNISzhWOGtTbGVWSnlhbzdyWl9zRURoQmVOV3lsQmRMcmtha2FkOGFBd0RsRmFuX2VDb2hHRjRCaEVTNzVTNkc1VXRTaXFHdDQwdGNhODFabmM0Y1FiSmZPODNhN2NOVUlyRHQ0b2hySjRNR0RRZWF5c1JZUWc?oc=5","date":"2025-10-23","type":"earnings","source":"The Business Journals","summary":"Fast 50: Lotus Pharmacy debuts at No. 1 with 562% revenue growth - The Business Journals","headline":"Fast 50: Lotus Pharmacy debuts at No. 1 with 562% revenue growth","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxPNkRoQjhCVEwzdVNwNzc1X2FpaWhEUUtNR0poblhmUmNSUVRWR2lrMUJyY21MMXJJZFZPUEx5bnRhZWlkcThjRlRkeWVYVzIzSVlUZERlVGh5ZWw5VkJWY19wZXo4TmRsalp6SHREWWtYS193cDY0VER3NVpPT1NIM1Zzbjg2MHZFSEhGbnRXVnhoZkRkX041TWdHRTlIemxYOVNaa29DcFgzNzZPV1VlcnJvU3FyQUh5clJxM2xPcmNSYTdlY2lCaDB6M0c?oc=5","date":"2025-10-09","type":"regulatory","source":"NAVLIN DAILY","summary":"Lotus Pharma to Commercialize Semaglutide Injection for Obesity in Southeast Asian Markets - NAVLIN DAILY","headline":"Lotus Pharma to Commercialize Semaglutide Injection for Obesity in Southeast Asian Markets","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4gFBVV95cUxPQ0pRejJRRkQ0UnVubnJTaHpaWFpHeEJmeXA0VklqTElNY2lXeXhRektPVU5iUkoxS2RLWXR1VE94dDlwel9fQ053TFZ5ZUt5UzZYTzNkeEUzZ0Q0d2JLZVNJZGJCSi1pajI4cXlFdVBFVlVNeEkxQVhkWFVJNi0xZXJMVGpObjlxT281TWVLYjlCdGtEQ2ZobDFXS01hd2lmc2NpcG44cUxOZjl6dmxDNW1xOHd2dFoxcno2ZjBkOUtLbDdpb1ZwRHFVX0hXajBFV1VQZXYweHIxUW5xRUt3NHRB?oc=5","date":"2025-10-08","type":"regulatory","source":"BioSpectrum Asia","summary":"Taiwan's Lotus Pharma to commercialise Semaglutide injection for obesity in multiple Asian markets - BioSpectrum Asia","headline":"Taiwan's Lotus Pharma to commercialise Semaglutide injection for obesity in multiple Asian markets","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxQNERGYTFPZjN0MWxuZG00ODFmckJ6aEZpMS1JeHo3TjZXc1VlVFhKNHljN1FpbTZaRkdhQTFoaXRRRTd1NWI5OFVxRWl2MnZaaHVKNDZHcGRlS1J1OU9TZUNjOGRVTDlZTHhnOEtQbTU5Y0JpcTRpcU8zQ0RIaUY1YkR3TnZNTElsZDc4ZV9ERW54TmhXcF95MXJDVGhUYUFRUUlwdlZnU2JTYzA?oc=5","date":"2025-09-26","type":"patent","source":"Fierce Pharma","summary":"Asian generics powerhouse Lotus expands US presence with acquisition of Alvogen - Fierce Pharma","headline":"Asian generics powerhouse Lotus expands US presence with acquisition of Alvogen","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxObkdWRkVaakV3eWdNSV80Nnc2NWJFVkxsY2NsaVh4S2hVdXJ1a3FlU3NiM1ItRzBta2I4SmJpWkd5X2kxYVZ3cEkydUdJa3kyRnNIU3plSDBsNFhkbXR4UnFKZ0NmWnJNdWRDdV9ia2RicWJYdjlLczcyRDVsQ2VHa0ZYcDJTN043ay1VcDJ2bW1TYXRHSGFidFNiX0llZw?oc=5","date":"2025-09-25","type":"pipeline","source":"White & Case LLP","summary":"White & Case advises Alvogen on sale to Lotus Pharmaceutical - White & Case LLP","headline":"White & Case advises Alvogen on sale to Lotus Pharmaceutical - White & Case LLP","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5AFBVV95cUxON0gtYnMwVGpvbVJxNlBJaXgzbGFHVm9sb3E0dEJ5YlRpT3JxdXJnaWU2V25maGNTUUpjWVZjNEF1MWhfRkp0MXdNems5N2F5c094cThhZWhkUU8tc0lURndVdE5EODJySm9ScGx3R2gyVlRGUGpVZHVMQXhOZm42a19VcVlDb3dTYzVEWTlwUUU5azh3ZHE2ZGxNNkhxMDFfdW1zWGVxWVVkZmtEYzl6WWZpQ2F1VXItT0JkeWRuWkpPRU9kQ25UdmdEOXRJTUdQOWFlSTByazBvZEJhbm1CWnFDVXM?oc=5","date":"2025-09-23","type":"patent","source":"prnewswire.com","summary":"Alvogen Announces Sale to Lotus, Creating a Leading International Specialized Generics Platform - prnewswire.com","headline":"Alvogen Announces Sale to Lotus, Creating a Leading International Specialized Generics Platform","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxPNzBZemVtb0w4eGdidE9FQXNrMlNMUlF5bVdjT21yYXpmMGZTR3ZGRS10bUMtS1diYlk5d2FpX0REbU1TQ2JTOEstZWw1czZVbXNaUVVNLWtOYTkwem5LSFU2ZzYzUWxMTXM5d1I1dTgxaV9lTEtTeC1lWl9JaWJmS0hzZ2VuQTBtWERpQnljUVJ4VGFzZ1FPZW1nenBNVkhFYU0w?oc=5","date":"2025-07-25","type":"pipeline","source":"Bangkok Post","summary":"PTT to sell stake in Taiwan pharmaceuticals firm - Bangkok Post","headline":"PTT to sell stake in Taiwan pharmaceuticals firm","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAJBVV95cUxPSk5tZ19XQ1lfMUxxLWlkNWYtMjR3NF92b2RfTmdBYlBBS2JUWXFpT0hKZVZCLS14VW9ka0tjODE2QnRjSTlOcGhybU9yY29KUnVhVFNpTVdXUmpqLVF1aGJvVmtEdHVfZ252S3JwZEg5aWtHeEdIdGpwcElhNFhldjlrMXZMSnNVckZBZzdDdTFHMlZ1OTFmWjhRZ0NmUl93SXctLWhmQjlsdElHRnFrbjRjVk1mMlhLRW9iSFlxUjJIenF4bENzaWZxWEUzNW83LUQta0FQTjRzeFFTYVRVWGVSbzBnTWc1bEFvQWx4MlJ5UUUzMFRxSGVwVnpxbHloLURyelNoTnNZZHdPZ2trczVPNjNHbWtnbXNsc3F0bGdKdm16dkl6b3NhbUNwZzlOV1g5WXIyQWsxZjhw?oc=5","date":"2025-05-09","type":"deal","source":"LENZ Therapeutics","summary":"LENZ Therapeutics and Lotus Pharmaceutical Announce Exclusive License and Commercialization Agreement for LNZ100 in the Republic of Korea and Southeast Asia - LENZ Therapeutics","headline":"LENZ Therapeutics and Lotus Pharmaceutical Announce Exclusive License and Commercialization Agreement for LNZ100 in the ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3gFBVV95cUxQXy1jRUp1X1Y3eEJBVXVOaXo5amJQVzhwQnBoMkxieVNvUzQ0T2VwbmFOSmRlLUh2OVFTYTVLRFpzMV9xZE1mQUFsQlgwSEtvQV9xcmFsNWJmOUZ1QjBDUDVUX004MVluT285dlVzMW1sRHNYUG1qelB0b0g1SnIzcUsxZEVZLXRDR0FJdzExaUswVTFRTGNFY2l3ZVBEZm8xaWZQa0tQaEw4cXdLak5iVHppVHh0dDVnNjYtdWx5MUd3b3ZzSnpxWFRYa3pRcmRaX3BLRHlWWkhmV2Y4M0E?oc=5","date":"2025-01-13","type":"deal","source":"Ophthalmology Times Europe","summary":"Teva partners with Klinge Biopharma, Lotus Pharmaceutical for commercialisation of Formycon’s FYB203 (biosimilar aflibercept) - Ophthalmology Times Europe","headline":"Teva partners with Klinge Biopharma, Lotus Pharmaceutical for commercialisation of Formycon’s FYB203 (biosimilar afliber","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxObEIzbV84TGxfbGZPYTZpU1VqUHgzOHRDbTA0aHBJWnNCcGFPR2RDWG1pZ1B2djBfd0FLYi1sSmM0YjFCdkI5ZTJoa3lhRVMtWDM1RWZIVC1SM0VuTjVNY0NfQzVwanJzakhSMUR5ZlU4YnhhdmFqOVgxVUZNZWhkX3kyOTZPU0Z4RmpjNFFR?oc=5","date":"2023-06-12","type":"pipeline","source":"Pharmaceutical Technology","summary":"Lotus Pharmaceuticals, Teraju Pharma to market products - Pharmaceutical Technology","headline":"Lotus Pharmaceuticals, Teraju Pharma to market products","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}